GH16-006: Conducting Public Health Research in Kenya
GH16-006: Conducting Public Health Research in Kenya
批准号:
9249936
负责人:
Art Hapner
金额:
$479.08万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-30 至 2021-09-29
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract/Summary
This proposal is submitted by the HJF Medical Research International (HJFMRI) in response to
announcement RFA-GH-16-006, Conducting Public Health Research in Kenya, a funding
opportunity from the Centers for Disease Control and Prevention (CDC). The purpose of this
cooperative agreement is to conduct and monitor epidemiologic, clinical- and laboratory-based
studies of important human diseases in Kenya. In collaboration with the Kenya Medical
Research Institute (KEMRI), we are applying for Components A, B, C, D and E. For Component
A, the Division of Global Health Protection, our proposal addresses, for example: surveillance
for infectious zoonotic diseases in animals, covering causes of diseases in livestock and
quantifying the linkages between the health of people and the animals with which they live; and
the role of pathogens in acute febrile illness (AFI), characterizing the epidemiology, including
seasonality of AFI. For Component B, our proposal covers, for example, identification of clinical,
epidemiologic and nutritional characteristics of patients hospitalized with respiratory illness and
risk factors, in settings like western Kenya, which may further predispose pregnant women to
severe outcomes from influenza, especially in relationship to influenza vaccination. For
Component C, we include proposed projects, such as determination of the effectiveness of
patient delivered partner therapy in reducing Chlamydia trachomatis and Neisseria gonorrhea
re-infection in conjunction with assessment of the prevalence and incidence of human
immunodeficiency virus (HIV) infection. For Component D, for instance, we consider measuring
schistosome antigens in oral fluid samples via detection of Circulating Cathodic Antigen (CCA)
and present a sampling design to assess the therapeutic efficacy of Artemisinin-based
combination therapies for symptomatic, uncomplicated P. falciparum infection among children.
Finally, for Component E, for example, we propose a study to measure the effectiveness of
three different strategies to increase the TB case detection rate compared to the standard
approach, Directly Observed Treatment (DOTS) as implemented in Kenya. Each of our
proposed projects is consistent with and beneficial to furthering CDC Kenya's mission to
promote health through collaboration on science, policy and evidence-based public health
actions. Collaborative public health research is HJFMRI's forte, and we offer our expertise in
management to fulfill CDC strategic priorities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
评价呼吸道合胞病毒二价mRNA疫苗(IN006)在60周岁及以上健康人群安全性和免疫原性的临床研究
-
批准号:2026JJ82041
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:赵俊仕
-
依托单位:
新型抗帕金森病候选药物T-006调控线粒体抑制小胶质细胞NLRP3炎性小体激活机理研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:陈海云
-
依托单位:
MEF2激活剂T-006对阿尔茨海默病的神经保护作用及机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:杨细飞
-
依托单位:
死亡受体5靶向分子探针89Zr-CTB006的构建及其在PET免疫显像中的研究
-
批准号:82102091
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:王淑静
-
依托单位:
毛果杨干旱胁迫响应基因PtrNAC006介导的木质部导管细胞形成的转录调控网络
-
批准号:32001331
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:李爽
-
依托单位:
circETS1/miR-1205/FoxP3通过抑制Treg促进SLE活动性的分子机制研究
-
批准号:82060305
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2020
-
负责人:张瑞仙
-
依托单位:
神经保护剂T-006调控线粒体促进神经元再生作用机理研究
-
批准号:81803512
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:陈海云
-
依托单位:
ALK二代抑制剂ZG006抗肿瘤药效学评价及克服Crizotinib耐药研究
-
批准号:81473243
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2014
-
负责人:艾菁
-
依托单位:
海洋放线菌ACMA006抗肿瘤活性物质抑制肝癌的实验研究
-
批准号:31300103
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:袁献温
-
依托单位:
T7/SHp介导nNOS-PSD-95解偶联剂ZL006双级脑靶向递药系统的构建及抗缺血性脑卒中研究
-
批准号:81273457
-
项目类别:面上项目
-
资助金额:67.0万元
-
批准年份:2012
-
负责人:徐群为
-
依托单位: